Literature DB >> 14628069

The rise and fall of genomic methylation in cancer.

Assam El-Osta1.   

Abstract

Changes in genomic methylation and its significance in carcinogenesis is in the spotlight once again, though the focus is not on the usual suspects, DNA hypermethylation and tumour suppressor gene (TSG) silencing. Several recent reports provide compelling evidence of the relevance of genomic hypomethylation in cancer. These findings provide the best evidence so far that links the loss of DNA methylation and chromosomal instability with cancer development. This review article discusses these recent findings and reflects on the antithetical association between DNA methylation and carcinogenesis and the re-examination of studies performed almost two decades ago.

Entities:  

Mesh:

Year:  2004        PMID: 14628069     DOI: 10.1038/sj.leu.2403218

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  9 in total

Review 1.  Epigenetic regulation of protein tyrosine phosphatases: potential molecular targets for cancer therapy.

Authors:  Samson T Jacob; Tasneem Motiwala
Journal:  Cancer Gene Ther       Date:  2005-08       Impact factor: 5.987

2.  Estrogen regulates DNA methyltransferase 3B expression in Ishikawa endometrial adenocarcinoma cells.

Authors:  Min Cui; Zeqing Wen; Zhongli Yang; Ji Chen; Fei Wang
Journal:  Mol Biol Rep       Date:  2008-12-24       Impact factor: 2.316

3.  Blocking beta-catenin binding to the ZBP1 promoter represses ZBP1 expression, leading to increased proliferation and migration of metastatic breast-cancer cells.

Authors:  Wei Gu; Feng Pan; Robert H Singer
Journal:  J Cell Sci       Date:  2009-06-01       Impact factor: 5.285

4.  Specific glioblastoma multiforme prognostic-subtype distinctions based on DNA methylation patterns.

Authors:  Huihui Ma; Chenggang Zhao; Zhiyang Zhao; Lizhu Hu; Fang Ye; Hongzhi Wang; Zhiyou Fang; Yuejin Wu; Xueran Chen
Journal:  Cancer Gene Ther       Date:  2019-10-16       Impact factor: 5.987

5.  Specific Glioma Prognostic Subtype Distinctions Based on DNA Methylation Patterns.

Authors:  Xueran Chen; Chenggang Zhao; Zhiyang Zhao; Hongzhi Wang; Zhiyou Fang
Journal:  Front Genet       Date:  2019-09-12       Impact factor: 4.599

6.  Oxidative stress due to radiation in CD34(+) hematopoietic progenitor cells: protection by IGF-1.

Authors:  Konstantina Floratou; Efstathia Giannopoulou; Anna Antonacopoulou; Marina Karakantza; George Adonakis; Dimitrios Kardamakis; Panagiota Matsouka
Journal:  J Radiat Res       Date:  2012-07-10       Impact factor: 2.724

7.  Gene expression profiling of epithelial ovarian tumours correlated with malignant potential.

Authors:  Susanne Warrenfeltz; Stephen Pavlik; Susmita Datta; Eileen T Kraemer; Benedict Benigno; John F McDonald
Journal:  Mol Cancer       Date:  2004-10-07       Impact factor: 27.401

8.  Driver mutations of cancer epigenomes.

Authors:  David M Roy; Logan A Walsh; Timothy A Chan
Journal:  Protein Cell       Date:  2014-03-14       Impact factor: 14.870

9.  Genome organization, instabilities, stem cells, and cancer.

Authors:  S Pazhanisamy; V Jyothi
Journal:  J Stem Cells Regen Med       Date:  2009-04-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.